Premature aging in uremia

Molecular and Cellular Biochemistry

Volumn 298, Issue 1-2, 2007, Pages 195-198

  Cohen, Burton D ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Advanced glycation end products; Gamma glutamic semialdehyde; Guanidinosuccinic acid; Maillard reaction; Reactive oxygen species

Indexed keywords

2 AMINOGLUTARALDEHYDIC ACID; ADVANCED GLYCATION END PRODUCT; ARGININE; ARGININOSUCCINIC ACID; GUANIDINOSUCCINIC ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; DIABETES MELLITUS; GLYCATION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MOLECULAR DYNAMICS; NEPHROTOXICITY; OXIDATION; PATHOPHYSIOLOGY; PREMATURE AGING; PROTEIN CROSS LINKING; UREMIA;

AGING, PREMATURE; ARGININOSUCCINIC ACID; CROSS-LINKING REAGENTS; EXTRACELLULAR MATRIX; GLUTAMATES; GUANIDINES; HUMANS; SUCCINATES; UREMIA;

EID: 34247273052     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9351-z     Document Type: Article

References (15)

1. Bonas J, Cohen B, Natelson S (1963) Separation and estimation of certain guanidine compounds. Application to human urine. Microchem J 7:63-77
2. Horowitz H, Cohen B, Martinez P, Papayoanou M (1967) Defective ADP-induced platelet factor 3 activation in uremia. Blood 30:331-340
3. Cohen B (1972) Aberrations of the urea cycle in uremia. In: Kluthe R, Berlyne G, Burton B (eds) Uremia: An international conference on pathogenesis, diagnosis, therapy. Georg Thieme Verlag, Stuttgart, pp 1-7
4. Cohen B, Patel H, Kornhauser R (1977) Alternate reasons for atherogenesis in uremia. Proc Clin Dialysis Transplant Forum 7:178-180
5. Aoyagi K, Shahrzad S, Iida S, Tomida C, Hirayama A, Nagase S, Takemura K, Koyama A, Ohba S, Narita M, Cohen B (2001) Role of nitric oxide in the synthesis of guanidinosuccinic acid, an activator of the N-methyl- D-aspartate receptor. Kidney Int 59:S93-S96
6. Cohen B, Patel H (1997) Glycine in acute renal tubular necrosis. In: DeDeyn B, Marescau B, Qureshi A, Mori A (eds) Guanidine Compounds in Biology and Medicine 2. John Libbey, London pp 273-277
7. Cohen B (2003) Methyl group deficiency and guanidine production in uremia. Mol Cell Biochem 244:31-36
8. Monnier U, Mustata G, Biemel K, Reihl O, Lederer M, Zhenyu D, Sell D (2005) Cross-linking of the extracellular matrix by the Maillard Reaction in aging and diabetes: An update on "a puzzle nearing resolution". Ann NY Acad Sci 1043:533-544
9. Levine R (2002) Carbonyl modified proteins in cellular regulation, Aging and disease. Free Rad Biol Med 32:790-796
10. Thornalley P, Langborg A, Minhas H (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucasone in the glycation of protein by glucose. Biochem J 344:109-116
11. Lee A, Cerami A (1990) Modification of proteins and nucleic acids by reducing sugars: Possible role in aging. In: Davis H (ed) Handbook of the biology of aging, 3rd edn. Acad Press, New York, pp 116-130
12. Thornalley P (2003) The enzymatic defense against glycation in health, disease and therapeutics: A symposium to examine the concept. Biochem Soc Trans 31:1341-1342
13. Requena J, Chao C, Levine R, Stadtman E (2001) Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci 98:69-74
14. Akagawa M, Sasaki D, Kurota Y, Suyama K (2005) Formation of alpha aminoadipic and gamma glutamic semialdehydes in proteins by the Maillard Reaction. Ann NY Acad Sci 1043:129-134
15. Agalou S, Ahmed N, Thornalley P, Dawnay A (2005) Removal of free advanced glycation end-products by hemodialysis. Ann NY Acad Sci 1043:922